Target intelligence / Profile preview

2'-Fucosyllactose (2'-FL)

Target
2'-FL
Molecular classification
Oligosaccharide, Human Milk Oligosaccharide, Trisaccharide, Carbohydrate
01

Overview

2'-Fucosyllactose (2'-FL) is a prominent trisaccharide and the most abundant human milk oligosaccharide (HMO), representing nearly 30% of the total HMO content in the milk of secretor-positive mothers (Bode, 2012, Glycobiology). It consists of a fucose unit linked to a lactose core via an alpha-1,2-glycosidic bond (PubChem CID 123831). Biologically, 2'-FL functions as a prebiotic by selectively stimulating the growth of beneficial gut bacteria, such as Bifidobacterium, which are crucial for establishing a healthy neonatal microbiome (Salli et al., 2019, Nutrients). Beyond its prebiotic role, 2'-FL acts as a soluble decoy receptor; its structure mimics the glycan binding sites on intestinal cells, allowing it to bind pathogens like Norovirus, Rotavirus, and Campylobacter jejuni, thereby preventing their attachment and subsequent infection (Weichert et al., 2016, Journal of Biological Chemistry). It also modulates the immune system by reducing the expression of pro-inflammatory cytokines and enhancing the integrity of the intestinal barrier (He et al., 2016, Pediatric Research). While 2'-FL is not a traditional therapeutic target like a receptor or enzyme, it is extensively utilized as a bioactive ingredient in infant formulas and is being explored for its potential to treat adult gastrointestinal disorders such as irritable bowel syndrome (Vandenplas et al., 2018, Nutrients).

Other names
2'-O-fucosyllactose2-fucosyllactosealpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-D-glucopyranoseFuc-alpha-1,2-Gal-beta-1,4-Glc
02

Mechanism of action

Acts as a prebiotic to selectively stimulate the growth of beneficial Bifidobacteria and serves as a soluble decoy receptor that mimics host cell surface glycans to prevent pathogen adhesion.

03

Biological functions

Prebiotic activityPathogen decoyImmune modulationGut barrier maintenanceNeurodevelopmental support
04

Disease associations

InfectionInflammationNecrotizing enterocolitisIrritable bowel syndromeAllergy
05

Safety considerations

Gastrointestinal tolerance at high dosesPotential for mild bloating or flatulence
06

Biomarkers

Bifidobacterium abundanceFecal 2'-fucosyllactose levelsSecretor status (FUT2 genotype)

Beyond the preview

Go deeper on 2'-Fucosyllactose (2'-FL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2'-Fucosyllactose (2'-FL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call